Kyung‐Sub Moon

4.1k total citations
159 papers, 3.1k citations indexed

About

Kyung‐Sub Moon is a scholar working on Epidemiology, Genetics and Neurology. According to data from OpenAlex, Kyung‐Sub Moon has authored 159 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Epidemiology, 48 papers in Genetics and 48 papers in Neurology. Recurrent topics in Kyung‐Sub Moon's work include Meningioma and schwannoma management (51 papers), Glioma Diagnosis and Treatment (48 papers) and Brain Metastases and Treatment (26 papers). Kyung‐Sub Moon is often cited by papers focused on Meningioma and schwannoma management (51 papers), Glioma Diagnosis and Treatment (48 papers) and Brain Metastases and Treatment (26 papers). Kyung‐Sub Moon collaborates with scholars based in South Korea, Bangladesh and China. Kyung‐Sub Moon's co-authors include Shin Jung, Tae‐Young Jung, In‐Young Kim, Woo‐Youl Jang, Kyung‐Hwa Lee, Soo-Han Kim, Jung-Kil Lee, Alex L. Tobias, Atique U. Ahmed and Sam-Suk Kang and has published in prestigious journals such as Nature Communications, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Kyung‐Sub Moon

151 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyung‐Sub Moon South Korea 30 831 693 693 639 566 159 3.1k
John A. Boockvar United States 37 1.3k 1.5× 689 1.0× 643 0.9× 856 1.3× 1.1k 1.9× 175 4.0k
Takanori Ohnishi Japan 33 715 0.9× 775 1.1× 432 0.6× 1.1k 1.8× 282 0.5× 146 3.5k
Hideaki Yokoo Japan 28 1000 1.2× 578 0.8× 362 0.5× 981 1.5× 280 0.5× 181 2.7k
Hans Maier Austria 29 417 0.5× 520 0.8× 496 0.7× 737 1.2× 431 0.8× 76 2.5k
Figen Söylemezoğlu Türkiye 32 1.2k 1.5× 868 1.3× 772 1.1× 805 1.3× 417 0.7× 195 3.6k
Bodo Lippitz Sweden 22 563 0.7× 1.1k 1.6× 627 0.9× 301 0.5× 340 0.6× 43 3.1k
Hideo Takeshima Japan 25 625 0.8× 511 0.7× 336 0.5× 765 1.2× 276 0.5× 123 2.3k
Anthony Béhin France 33 773 0.9× 781 1.1× 673 1.0× 1.6k 2.6× 318 0.6× 145 3.9k
Herbert H. Engelhard United States 29 1.2k 1.4× 634 0.9× 425 0.6× 759 1.2× 503 0.9× 88 2.8k
Songtao Qi China 32 1.2k 1.4× 427 0.6× 675 1.0× 1.8k 2.8× 585 1.0× 252 4.1k

Countries citing papers authored by Kyung‐Sub Moon

Since Specialization
Citations

This map shows the geographic impact of Kyung‐Sub Moon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyung‐Sub Moon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyung‐Sub Moon more than expected).

Fields of papers citing papers by Kyung‐Sub Moon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyung‐Sub Moon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyung‐Sub Moon. The network helps show where Kyung‐Sub Moon may publish in the future.

Co-authorship network of co-authors of Kyung‐Sub Moon

This figure shows the co-authorship network connecting the top 25 collaborators of Kyung‐Sub Moon. A scholar is included among the top collaborators of Kyung‐Sub Moon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyung‐Sub Moon. Kyung‐Sub Moon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Koo, John, Sung Sun Kim, Ji Shin Lee, et al.. (2025). Claudin 18.2 expression profile in primary tumors and their ovarian metastases: implications for targeted therapy. BMC Cancer. 25(1). 540–540. 1 indexed citations
3.
Lim, Sa-Hoe, Yeong Jin Kim, Kyung‐Sub Moon, et al.. (2024). Leksell Frame-Based Stereotactic Biopsy for Infratentorial Tumor : Practical Tips and Considerations. Journal of Korean Neurosurgical Society. 67(2). 249–256. 3 indexed citations
4.
Lee, Joo-Hwan, In‐Young Kim, Shin Jung, et al.. (2023). Two-Day Fraction Gamma Knife Radiosurgery for Large Brain Metastasis. Journal of Korean Neurosurgical Society. 67(5). 560–567.
5.
Chin, Susie, et al.. (2023). The significance of programed cell death‐ligand 1 expression in vestibular schwannoma. Brain and Behavior. 13(9). e3137–e3137. 1 indexed citations
6.
Jung, Tae‐Young, et al.. (2022). Meningioma With Partial and Spontaneous Regression of Peritumoral Edema on Long-Term Follow Up. Brain Tumor Research and Treatment. 10(4). 275–275. 2 indexed citations
7.
Kim, Dong‐Yeon, Ayoung Pyo, Sung-Hwan You, et al.. (2022). In vivo imaging of invasive aspergillosis with 18F-fluorodeoxysorbitol positron emission tomography. Nature Communications. 13(1). 1926–1926. 21 indexed citations
8.
Kang, Ho, Jong Jin Lee, Seung Won Choi, et al.. (2021). Radiological assessment schedule for 1p/19q-codeleted gliomas during the surveillance period using parametric modeling. Neuro-Oncology Advances. 3(1). vdab069–vdab069.
9.
Kim, In‐Young, Young‐Jin Kim, Tae‐Young Jung, et al.. (2021). Lorlatinib Therapy for Rapid and Dramatic Control of Brain and Spinal Leptomeningeal Metastases From ALK-Positive Lung Adenocarcinoma. Brain Tumor Research and Treatment. 9(2). 100–100. 6 indexed citations
10.
Jung, Shin, Inyoung Kim, Kyung‐Sub Moon, et al.. (2021). Branched Multipeptide-combined Adjuvants Potentially Improve the Antitumor Effects on Glioblastoma. Journal of Immunotherapy. 44(4). 151–161. 1 indexed citations
11.
Noh, Myung‐Giun, Sung Sun Kim, Yeong Jin Kim, et al.. (2021). Evolution of the Tumor Microenvironment toward Immune-Suppressive Seclusion during Brain Metastasis of Breast Cancer: Implications for Targeted Therapy. Cancers. 13(19). 4895–4895. 17 indexed citations
12.
Akanda, Md Rashedunnabi, Jee Soo Park, Myung‐Giun Noh, et al.. (2021). TACC3 Promotes Gastric Carcinogenesis by Promoting Epithelial-mesenchymal Transition Through the ERK/Akt/cyclin D1 Signaling Pathway. Anticancer Research. 41(7). 3349–3361. 4 indexed citations
14.
Kim, In‐Young, et al.. (2017). Resection and Observation for Brain Metastasis without Prompt Postoperative Radiation Therapy. Journal of Korean Neurosurgical Society. 60(6). 667–675. 3 indexed citations
15.
Noh, Myung‐Giun, Yeong Jin Kim, Tae‐Young Jung, et al.. (2017). Prognostic significance of E-cadherin and N-cadherin expression in Gliomas. BMC Cancer. 17(1). 583–583. 71 indexed citations
16.
Wainwright, Derek A., Irina V. Balyasnikova, Alan L. Chang, et al.. (2012). IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival. Clinical Cancer Research. 18(22). 6110–6121. 378 indexed citations
17.
Jung, Tae‐Young, Shin Jung, Shu‐Guang Jin, et al.. (2009). THE CORRELATION AND PROGNOSTIC SIGNIFICANCE OF MGMT PROMOTER METHYLATION AND MGMT PROTEIN IN GLIOBLASTOMAS. Neurosurgery. 65(5). 866–875. 96 indexed citations
18.
Joo, Sung-Pil, et al.. (2007). Characteristics and management of ruptured distal middle cerebral artery aneurysms. Acta Neurochirurgica. 149(7). 661–667. 29 indexed citations
19.
Moon, Kyung‐Sub, Jung-Kil Lee, Tae‐Sun Kim, et al.. (2007). Contralateral acute subdural hematoma occurring after removal of calcified chronic subdural hematoma. Journal of Clinical Neuroscience. 14(3). 283–286. 32 indexed citations
20.
Moon, Kyung‐Sub, et al.. (2006). Benign osteoblastoma of the occipital bone: Case report and literature review. Neuropathology. 26(2). 141–146. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026